Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature

Objective Recent publications on Coronavirus Disease-2019 (COVID-19) report that diabetic people with or without co-morbidities are at higher risk of developing severe and/or fatal illnesses. Method and Result We report the first case of a 60-year-old man with a 27-year history of type 1 diabetes mellitus, infected by SARS-CoV-2 presenting with an euglycaemic ketoacidosis and an acute respiratory distress syndrome Conclusion This case report reminds us of the importance of adjusting more recent glucose-lowering drugs, including sodium-glucose cotransporter 2 inhibitors, in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.

Automated summary

Recent publications have shown that individuals with diabetes are at higher risk of developing severe and/or fatal illnesses from COVID-19. This case report highlights the importance of adjusting glucose-lowering drugs in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.